Six-Month Results of the World's First VASC Clinical Trial for Endovascular NTNT Treatment of GSV Through Empty Vein Ablation Using Velex ™
To report six-month results from the VASC (Vacuum Assisted Sclerotherapy Catheter) study, a multicentric, prospective, non-randomized trial with the primary objective to confirm safety and efficacy of Velex for empty vein ablation (EVA) of the great saphenous vein (GSV; ClinicalTrials.gov, NCT05581524).
Source: Journal of Vascular Surgery - Category: Surgery Authors: Paolo Righini, Daniela Mazzaccaro, Claudia Cesi, Domenico Baccellieri, Giovanni Nano Source Type: research